Dempsey Photo Nov 2020 rsz
Chief Executive Officer and President

Robert J. Dempsey, MBA

Robert brings more than two decades of domestic and global experience in the ophthalmic space building organizations, driving successful drug development, and transacting companies and products to deliver shareholder value and improve patient outcomes
CSO, EVP-Clinical Development

Amir Shojaei, Pharm.D., Ph.D.

Amir has built a career in life sciences as a leader with over two and a half decades of drug development experience, focused on the clinical development, registration and commercialization of biopharmaceuticals and biologics in multiple therapeutic areas.
VP, Research & Innovation - Head of Non-Clinical

Niranjan B. Pandey, Ph.D.

Dr. Pandey is Vice President, Research and Development at AsclepiX Therapeutics. Dr. Pandey is responsible for guiding scientific discovery and research of the company.
Jill Final
Director of Finance

Jill Tierney

Jill joined AsclepiX with over 15 years of experience in corporate finance, financial planning and analysis in the pharmaceutical and healthcare industries.
Jordan Green
Founder, Chief Technology Advisor

Jordan J. Green, Ph.D.

Dr. Green is the Founder and Chief Technology Advisor of AsclepiX Therapeutics and responsible for guiding technical directions of the company.
Founder, Chief Scientific Advisor

Aleksander S. Popel, Ph.D.

Dr. Popel is the Founder and Chief Scientific Advisor of AsclepiX Therapeutics and responsible for guiding scientific directions of the company.